The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.

Saved in:
Bibliographic Details
Title: The deletion variant of α2b-adrenergic receptor is associated with decreased risk in Alzheimer's disease and mild cognitive impairment.
Authors: Koutroumani M; Laboratory of Biochemistry, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki, Greece., Daniilidou M, Giannakouros T, Proitsi P, Liapi D, Germanou A, Nikolakaki E, Tsolaki M
Source: Journal of the neurological sciences [J Neurol Sci] 2013 May 15; Vol. 328 (1-2), pp. 19-23. Date of Electronic Publication: 2013 Mar 15.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 0375403 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-5883 (Electronic) Linking ISSN: 0022510X NLM ISO Abbreviation: J Neurol Sci Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1878-5883
DOI:10.1016/j.jns.2013.02.003